Anna Lembke
Biographic Data
| ID | 1541194 |
|---|---|
| NAME | Anna Lembke |
| GIVEN NAMES | Anna |
| FAMILY NAME | Lembke |
| SIGNATURE | LEMBKE A |
| AFFILIATIONS | Stanford University |
| ORCID | 0000-0002-1352-487X |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
La dopamine joue un rôle clé
Según el estado actual de los conocimientos y un relativo consenso internacional, la identificación del alto potencial intelectual requiere una evaluación psicológica y una prueba homologada de inteligencia que conduzca a una puntuación general del Cociente Intelectual (CI) igual o superior a 130, lo que corresponde al 2,3 por ciento de la población. Esto concierne a cerca de 370 000 jóvenes menores de 20 años en Francia. Principalmente realizado…
Responding to the opioid crisis in North America and beyond
Buprenorphine Microdosing Cross Tapers
Buprenorphine is a partial opioid agonist that is Food and Drug Administration (FDA) approved to treat chronic pain and opioid use disorder (OUD). The national prescribing guidelines in the United States (US) recommend that patients transitioning from full opioid agonists to buprenorphine first undergo 12 or more hours of active opioid withdrawal, in order to avoid buprenorphine-precipitated opioid withdrawal. This opioid-free period imposes a si…
A call to include people with mental illness and substance use disorders alongside ‘regular’ smokers in smoking cessation research
This commentary points out that smoking is increasingly concentrated among people with psychiatric problems and other substance use disorders (eg, alcohol use disorder), and argues that for clinical, ethical and efficiency reasons, such individuals should be routinely enrolled in smoking cessation research
No prominent works on this page.
A call to include people with mental illness and substance use disorders alongside ‘regular’ smokers in smoking cessation research
This commentary points out that smoking is increasingly concentrated among people with psychiatric problems and other substance use disorders (eg, alcohol use disorder), and argues that for clinical, ethical and efficiency reasons, such individuals should be routinely enrolled in smoking cessation research
Responding to the opioid crisis in North America and beyond
Buprenorphine Microdosing Cross Tapers
Buprenorphine is a partial opioid agonist that is Food and Drug Administration (FDA) approved to treat chronic pain and opioid use disorder (OUD). The national prescribing guidelines in the United States (US) recommend that patients transitioning from full opioid agonists to buprenorphine first undergo 12 or more hours of active opioid withdrawal, in order to avoid buprenorphine-precipitated opioid withdrawal. This opioid-free period imposes a si…
La dopamine joue un rôle clé
Según el estado actual de los conocimientos y un relativo consenso internacional, la identificación del alto potencial intelectual requiere una evaluación psicológica y una prueba homologada de inteligencia que conduzca a una puntuación general del Cociente Intelectual (CI) igual o superior a 130, lo que corresponde al 2,3 por ciento de la población. Esto concierne a cerca de 370 000 jóvenes menores de 20 años en Francia. Principalmente realizado…
Medicine (3 works) · Internal Medicine (2 works) · Opioid (2 works) · Opioid Use Disorder Treatment (2 works) · Substance Abuse Treatment and Outcomes (2 works) · Agonist (1 work) · Alcohol (1 work) · Alcohol use disorder (1 work) · Anesthesia (1 work) · Art (1 work)